Afyren: signature of two new strategic contracts for AFYREN NEOXY for the nutrition and health markets





Photo credit © Reuters

(Boursier.com) – AFYREN , a greentech company that offers manufacturers natural and low-carbon products thanks to its technology based on natural microorganisms, announces that it has signed two strategic contracts for the long-term supply of bio-based ingredients by AFYREN NEOXY from two major players in the nutrition (human and animal) and health markets.

These two contracts were established with benchmark partners, leaders in their respective sectors:
-the first for the manufacture of high quality food ingredients, in particular for the confectionery, meat, chocolate and dairy products markets;
-the second for the manufacture of nutritional and health solutions dedicated to animals.

The markets addressed by these new partners show significant growth potential and experience increased demand for natural and bio-based solutions from consumers. AFYREN responds to these trends by ensuring a local supply chain for raw materials operated by its AFYREN NEOXY plant and by its innovative proprietary technology platform.
Taking into account these new agreements, 60% (by volume) of the target organic acid production of the AFYREN NEOXY plant is already pre-sold.

Nicolas Sordet, Chief Executive Officer of AFYREN declares: “As an extension of the recently announced partnership with ENNOLYS, these two new agreements reinforce the attractiveness of our products and our unique positioning based on a circular economy and zero industrial waste approach. . The markets that we are going to address, which are growing steadily, are experiencing significant demand for sustainable and biobased ingredients, stimulated by consumers in demand for healthier and more responsible habits. animal nutrition and human food, we are further securing the future turnover of AFYREN NEOXY while positioning ourselves as a benchmark supplier of bio-based organic acids at European level. This allows us to continue to secure the start-up of this first factory, and thus to approach its rise in power calmly. “


© 2021 Boursier.com





Source link -87